Rosiglitazone Protects Endothelial Cells From Irradiation-Induced Mitochondrial Dysfunction
Open Access
- 13 March 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 268
Abstract
Background and Purpose. Up to 50 – 60% of all cancer patients receive radiotherapy as part of their treatment strategy. However, the mechanisms accounting for increased vascular risks after irradiation are not completely understood. Mitochondrial dysfunction has been identified as a potential cause of radiation-induced atherosclerosis. Material and Methods. Assays for apoptosis, cellular metabolism, mitochondrial DNA content, functionality and morphology were used to compare the response of endothelial cells to a single 2 Gy dose of X-rays under basal conditions or after pharmacological treatments that either reduced (EtBr) or increased (rosiglitazone) mitochondrial content. Results. Exposure to ionizing radiation caused a persistent reduction in mitochondrial content of endothelial cells. Pharmacological reduction of mitochondrial DNA content rendered endothelial cells more vulnerable to radiation-induced apoptosis, whereas rosiglitazone treatment increased oxidative metabolism and redox state and decreased the levels of apoptosis after irradiation. Conclusions. Pre-existing mitochondrial damage sensitizes endothelial cells to ionizing radiation-induced mitochondrial dysfunction. Rosiglitazone protects endothelial cells from the detrimental effects of radiation exposure on mitochondrial metabolism and oxidative stress. Thus, our findings indicate that rosiglitazone may have potential value as prophylactic for radiation-induced atherosclerosis.Keywords
Funding Information
- Seventh Framework Programme
- Fonds De La Recherche Scientifique - FNRS
This publication has 42 references indexed in Scilit:
- Computational classification of mitochondrial shapes reflects stress and redox stateCell Death & Disease, 2013
- Mitochondria in vascular diseaseCardiovascular Research, 2012
- Rosiglitazone-Induced Mitochondrial Biogenesis in White Adipose Tissue Is Independent of Peroxisome Proliferator-Activated Receptor γ Coactivator-1αPLOS ONE, 2011
- Non-cancer diseases and non-targeted effectsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2010
- Mitochondrial Complex II Dysfunction Can Contribute Significantly to Genomic Instability after Exposure to Ionizing RadiationRadiation Research, 2009
- Radioprotection by short‐term oxidative preconditioning: Role of manganese superoxide dismutaseFEBS Letters, 2009
- TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesisBiochemical and Biophysical Research Communications, 2009
- Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in miceJournal of Clinical Investigation, 2008
- Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery diseaseMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Termination detection by using distributed snapshotsInformation Processing Letters, 1989